PD
The startup develops a lung cancer early detection test that utilizes advanced diagnostic techniques to identify disease cases at an early stage. This technology enables patients and healthcare providers to make informed decisions, significantly improving the chances of successful treatment outcomes.
Updated 3 months ago
Funding
$2.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a lung cancer early detection test that utilizes advanced diagnostic techniques to identify disease cases at an early stage. This technology enables patients and healthcare providers to make informed decisions, significantly improving the chances of successful treatment outcomes.